{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T11:25:53Z","timestamp":1794050753141,"version":"4.8.0"},"reference-count":98,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2020,6,15]],"date-time":"2020-06-15T00:00:00Z","timestamp":1592179200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,6,15]],"date-time":"2020-06-15T00:00:00Z","timestamp":1592179200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Rev Rheumatol"],"published-print":{"date-parts":[[2020,7]]},"DOI":"10.1038\/s41584-020-0441-1","type":"journal-article","created":{"date-parts":[[2020,6,15]],"date-time":"2020-06-15T09:04:06Z","timestamp":1592211846000},"page":"380-390","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1310,"title":["Global epidemiology of gout: prevalence, incidence, treatment patterns and risk factors"],"prefix":"10.1038","volume":"16","author":[{"given":"Mats","family":"Dehlin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4402-148X","authenticated-orcid":false,"given":"Lennart","family":"Jacobsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8954-7082","authenticated-orcid":false,"given":"Edward","family":"Roddy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,6,15]]},"reference":[{"key":"441_CR1","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1038\/nrrheum.2015.91","volume":"11","author":"CF Kuo","year":"2015","unstructured":"Kuo, C. F., Grainge, M. J., Zhang, W. & Doherty, M. Global epidemiology of gout: prevalence, incidence and risk factors. Nat. Rev. Rheumatol. 11, 649\u2013662 (2015).","journal-title":"Nat. Rev. Rheumatol."},{"key":"441_CR2","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1007\/s10654-014-9927-y","volume":"30","author":"JM Wijnands","year":"2015","unstructured":"Wijnands, J. M. et al. Determinants of the prevalence of gout in the general population: a systematic review and meta-regression. Eur. J. Epidemiol. 30, 19\u201333 (2015).","journal-title":"Eur. J. Epidemiol."},{"key":"441_CR3","doi-asserted-by":"publisher","first-page":"1702","DOI":"10.3899\/jrheum.150310","volume":"42","author":"PC Robinson","year":"2015","unstructured":"Robinson, P. C., Taylor, W. J. & Dalbeth, N. An observational study of gout prevalence and quality of care in a national Australian general practice population. J. Rheumatol. 42, 1702\u20131707 (2015).","journal-title":"J. Rheumatol."},{"key":"441_CR4","doi-asserted-by":"publisher","DOI":"10.1186\/s12891-018-1941-x","volume":"19","author":"DA Gonzalez-Chica","year":"2018","unstructured":"Gonzalez-Chica, D. A., Vanlint, S., Hoon, E. & Stocks, N. Epidemiology of arthritis, chronic back pain, gout, osteoporosis, spondyloarthropathies and rheumatoid arthritis among 1.5 million patients in Australian general practice: NPS MedicineWise MedicineInsight dataset. BMC Musculoskelet. Disord. 19, 20 (2018).","journal-title":"BMC Musculoskelet. Disord."},{"key":"441_CR5","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1111\/imj.13006","volume":"46","author":"K Ting","year":"2016","unstructured":"Ting, K., Gill, T. K., Keen, H., Tucker, G. R. & Hill, C. L. Prevalence and associations of gout and hyperuricaemia: results from an Australian population-based study. Intern. Med. J. 46, 566\u2013573 (2016).","journal-title":"Intern. Med. J."},{"key":"441_CR6","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1186\/s13075-018-1633-9","volume":"20","author":"HL Pisaniello","year":"2018","unstructured":"Pisaniello, H. L. et al. Gout prevalence and predictors of urate-lowering therapy use: results from a population-based study. Arthritis Res. Ther. 20, 143 (2018).","journal-title":"Arthritis Res. Ther."},{"key":"441_CR7","doi-asserted-by":"publisher","first-page":"3136","DOI":"10.1002\/art.30520","volume":"63","author":"Y Zhu","year":"2011","unstructured":"Zhu, Y., Pandya, B. J. & Choi, H. K. Prevalence of gout and hyperuricemia in the US general population: the National Health and Nutrition Examination Survey 2007\u20132008. Arthritis Rheum. 63, 3136\u20133141 (2011).","journal-title":"Arthritis Rheum."},{"key":"441_CR8","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1002\/art.40807","volume":"71","author":"M Chen-Xu","year":"2019","unstructured":"Chen-Xu, M., Yokose, C., Rai, S. K., Pillinger, M. H. & Choi, H. K. Contemporary prevalence of gout and hyperuricemia in the United States and decadal trends: the National Health and Nutrition Examination Survey, 2007\u20132016. Arthritis Rheumatol. 71, 991\u2013999 (2019).","journal-title":"Arthritis Rheumatol."},{"key":"441_CR9","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1016\/j.semarthrit.2016.08.006","volume":"46","author":"SK Rai","year":"2017","unstructured":"Rai, S. K. et al. The rising prevalence and incidence of gout in British Columbia, Canada: population-based trends from 2000 to 2012. Semin. Arthritis Rheum. 46, 451\u2013456 (2017).","journal-title":"Semin. Arthritis Rheum."},{"key":"441_CR10","unstructured":"Health Canada. Arthritis in Canada: an Ongoing Challenge (Health Canada, 2003)."},{"key":"441_CR11","doi-asserted-by":"publisher","DOI":"10.1136\/rmdopen-2015-000166","volume":"2","author":"JC Branco","year":"2016","unstructured":"Branco, J. C. et al. Prevalence of rheumatic and musculoskeletal diseases and their impact on health-related quality of life, physical function and mental health in Portugal: results from EpiReumaPt \u2013 a national health survey. RMD Open 2, e000166 (2016).","journal-title":"RMD Open"},{"key":"441_CR12","doi-asserted-by":"publisher","DOI":"10.1136\/rmdopen-2016-000326","volume":"2","author":"MC Kapetanovic","year":"2016","unstructured":"Kapetanovic, M. C. et al. Prevalence and incidence of gout in southern Sweden from the socioeconomic perspective. RMD Open 2, e000326 (2016).","journal-title":"RMD Open"},{"key":"441_CR13","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1186\/s13075-016-1062-6","volume":"18","author":"M Dehlin","year":"2016","unstructured":"Dehlin, M., Drivelegka, P., Sigurdardottir, V., Svard, A. & Jacobsson, L. T. Incidence and prevalence of gout in Western Sweden. Arthritis Res. Ther. 18, 164 (2016).","journal-title":"Arthritis Res. Ther."},{"key":"441_CR14","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1016\/j.ypmed.2015.10.003","volume":"81","author":"P Wandell","year":"2015","unstructured":"Wandell, P., Carlsson, A. C. & Ljunggren, G. Gout and its comorbidities in the total population of Stockholm. Prev. Med. 81, 387\u2013391 (2015).","journal-title":"Prev. Med."},{"key":"441_CR15","doi-asserted-by":"publisher","DOI":"10.1186\/s12891-015-0536-z","volume":"16","author":"JM Kinge","year":"2015","unstructured":"Kinge, J. M., Knudsen, A. K., Skirbekk, V. & Vollset, S. E. Musculoskeletal disorders in Norway: prevalence of chronicity and use of primary and specialist health care services. BMC Musculoskelet. Disord. 16, 75 (2015).","journal-title":"BMC Musculoskelet. Disord."},{"key":"441_CR16","doi-asserted-by":"publisher","first-page":"836","DOI":"10.1093\/rheumatology\/key390","volume":"58","author":"K Zobbe","year":"2019","unstructured":"Zobbe, K. et al. Secular trends in the incidence and prevalence of gout in Denmark from 1995 to 2015: a nationwide register-based study. Rheumatology 58, 836\u2013839 (2019).","journal-title":"Rheumatology"},{"key":"441_CR17","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0138492","volume":"10","author":"SY Zeng","year":"2015","unstructured":"Zeng, S. Y. et al. Changes in the prevalence of rheumatic diseases in Shantou, China, in the past three decades: a COPCORD study. PLoS ONE 10, e0138492 (2015).","journal-title":"PLoS ONE"},{"key":"441_CR18","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1007\/s10389-017-0812-5","volume":"25","author":"YZ Chen","year":"2017","unstructured":"Chen, Y. Z. et al. The prevalence of gout in mainland China from 2000 to 2016: a systematic review and meta-analysis. J. Public Health 25, 521\u2013529 (2017).","journal-title":"J. Public Health"},{"key":"441_CR19","doi-asserted-by":"publisher","first-page":"1499","DOI":"10.1007\/s00296-017-3768-4","volume":"37","author":"JW Kim","year":"2017","unstructured":"Kim, J. W. et al. Prevalence and incidence of gout in Korea: data from the national health claims database 2007-2015. Rheumatol. Int. 37, 1499\u20131506 (2017).","journal-title":"Rheumatol. Int."},{"key":"441_CR20","doi-asserted-by":"publisher","first-page":"117","DOI":"10.5001\/omj.2016.23","volume":"31","author":"J Al Saleh","year":"2016","unstructured":"Al Saleh, J., Sayed, M. E., Monsef, N. & Darwish, E. The prevalence and the determinants of musculoskeletal diseases in Emiratis attending primary health care clinics in Dubai. Oman Med. J. 31, 117\u2013123 (2016).","journal-title":"Oman Med. J."},{"key":"441_CR21","doi-asserted-by":"publisher","first-page":"2509","DOI":"10.1007\/s10067-017-3648-z","volume":"36","author":"UU Courage","year":"2017","unstructured":"Courage, U. U. et al. Prevalence of musculoskeletal diseases in a semi-urban Nigerian community: results of a cross-sectional survey using COPCORD methodology. Clin. Rheumatol. 36, 2509\u20132516 (2017).","journal-title":"Clin. Rheumatol."},{"key":"441_CR22","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.1007\/s00296-016-3446-y","volume":"36","author":"S Guevara-Pacheco","year":"2016","unstructured":"Guevara-Pacheco, S. et al. Prevalence of musculoskeletal disorders and rheumatic diseases in Cuenca, Ecuador: a WHO-ILAR COPCORD study. Rheumatol. Int. 36, 1195\u20131204 (2016).","journal-title":"Rheumatol. Int."},{"key":"441_CR23","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1007\/s10067-016-3525-1","volume":"36","author":"P Wandell","year":"2017","unstructured":"Wandell, P. et al. Gout in immigrant groups: a cohort study in Sweden. Clin. Rheumatol. 36, 1091\u20131102 (2017).","journal-title":"Clin. Rheumatol."},{"key":"441_CR24","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2474-11-98","volume":"11","author":"I Anagnostopoulos","year":"2010","unstructured":"Anagnostopoulos, I. et al. The prevalence of rheumatic diseases in central Greece: a population survey. BMC Musculoskelet. Disord. 11, 98 (2010).","journal-title":"BMC Musculoskelet. Disord."},{"key":"441_CR25","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.reuma.2012.06.014","volume":"9","author":"A Sicras-Mainar","year":"2013","unstructured":"Sicras-Mainar, A., Navarro-Artieda, R. & Ibanez-Nolla, J. Resource use and economic impact of patients with gout: a multicenter, population-wide study. Reumatol. Clin. 9, 94\u2013100 (2013).","journal-title":"Reumatol. Clin."},{"key":"441_CR26","doi-asserted-by":"publisher","first-page":"574","DOI":"10.3899\/jrheum.170806","volume":"45","author":"MM Elfishawi","year":"2018","unstructured":"Elfishawi, M. M. et al. The rising incidence of gout and the increasing burden of comorbidities: a population-based study over 20 years. J. Rheumatol. 45, 574\u2013579 (2018).","journal-title":"J. Rheumatol."},{"key":"441_CR27","doi-asserted-by":"publisher","first-page":"95","DOI":"10.3899\/jrheum.160300","volume":"44","author":"A Fischer","year":"2017","unstructured":"Fischer, A. et al. The direct economic burden of gout in an elderly Canadian population. J. Rheumatol. 44, 95\u2013101 (2017).","journal-title":"J. Rheumatol."},{"key":"441_CR28","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1186\/s13075-018-1697-6","volume":"20","author":"MC Kapetanovic","year":"2018","unstructured":"Kapetanovic, M. C. et al. The risk of clinically diagnosed gout by serum urate levels: results from 30 years follow-up of the Malmo Preventive Project cohort in southern Sweden. Arthritis Res. Ther. 20, 190 (2018).","journal-title":"Arthritis Res. Ther."},{"key":"441_CR29","unstructured":"Aitken, M. J. Developments in Gout Treatment: New Approaches to an Old Disease (Nova, 2017)."},{"key":"441_CR30","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1002\/art.39840","volume":"69","author":"KG Saag","year":"2017","unstructured":"Saag, K. G. et al. Lesinurad combined with allopurinol: a randomized, double-blind, placebo-controlled study in gout patients with an inadequate response to standard-of-care allopurinol (a US-based study). Arthritis Rheumatol. 69, 203\u2013212 (2017).","journal-title":"Arthritis Rheumatol."},{"key":"441_CR31","doi-asserted-by":"publisher","first-page":"1903","DOI":"10.1002\/art.40159","volume":"69","author":"N Dalbeth","year":"2017","unstructured":"Dalbeth, N. et al. Lesinurad, a selective uric acid reabsorption inhibitor, in combination with febuxostat in patients with tophaceous gout: findings of a phase III clinical trial. Arthritis Rheumatol. 69, 1903\u20131913 (2017).","journal-title":"Arthritis Rheumatol."},{"key":"441_CR32","doi-asserted-by":"publisher","first-page":"1765","DOI":"10.1136\/annrheumdis-2012-201687","volume":"71","author":"M Doherty","year":"2012","unstructured":"Doherty, M. et al. Gout: why is this curable disease so seldom cured? Ann. Rheum. Dis. 71, 1765\u20131770 (2012).","journal-title":"Ann. Rheum. Dis."},{"key":"441_CR33","doi-asserted-by":"publisher","first-page":"228","DOI":"10.3904\/kjim.2016.429","volume":"33","author":"JW Kim","year":"2018","unstructured":"Kim, J. W., Kwak, S. G. & Park, S. H. Prescription pattern of urate-lowering therapy in Korean gout patients: data from the national health claims database. Korean J. Intern. Med. 33, 228\u2013229 (2018).","journal-title":"Korean J. Intern. Med."},{"key":"441_CR34","doi-asserted-by":"publisher","first-page":"2684","DOI":"10.1001\/jama.2014.14484","volume":"312","author":"CF Kuo","year":"2014","unstructured":"Kuo, C. F., Grainge, M. J., Mallen, C., Zhang, W. & Doherty, M. Eligibility for and prescription of urate-lowering treatment in patients with incident gout in England. JAMA 312, 2684\u20132686 (2014).","journal-title":"JAMA"},{"key":"441_CR35","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/s13075-016-1211-y","volume":"19","author":"M Dehlin","year":"2017","unstructured":"Dehlin, M. et al. Factors associated with initiation and persistence of urate-lowering therapy. Arthritis Res. Ther. 19, 6 (2017).","journal-title":"Arthritis Res. Ther."},{"key":"441_CR36","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1016\/j.semarthrit.2017.09.007","volume":"47","author":"LEJM Scheepers","year":"2018","unstructured":"Scheepers, L. E. J. M. et al. Medication adherence among patients with gout: a systematic review and meta-analysis. Semin. Arthritis Rheum. 47, 689\u2013702 (2018).","journal-title":"Semin. Arthritis Rheum."},{"key":"441_CR37","doi-asserted-by":"publisher","first-page":"1641","DOI":"10.1093\/rheumatology\/key155","volume":"57","author":"LEJM Scheepers","year":"2018","unstructured":"Scheepers, L. E. J. M. et al. Medication adherence among gout patients initiated allopurinol: a retrospective cohort study in the Clinical Practice Research Datalink (CPRD). Rheumatology 57, 1641\u20131650 (2018).","journal-title":"Rheumatology"},{"key":"441_CR38","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1007\/s10067-014-2823-8","volume":"35","author":"B McGowan","year":"2016","unstructured":"McGowan, B., Bennett, K., Silke, C. & Whelan, B. Adherence and persistence to urate-lowering therapies in the Irish setting. Clin. Rheumatol. 35, 715\u2013721 (2016).","journal-title":"Clin. Rheumatol."},{"key":"441_CR39","doi-asserted-by":"publisher","first-page":"e213","DOI":"10.1111\/jocn.13918","volume":"27","author":"XHJ Chua","year":"2018","unstructured":"Chua, X. H. J. et al. Factors influencing medication adherence in patients with gout: a descriptive correlational study. J. Clin. Nurs. 27, e213\u2013e222 (2018).","journal-title":"J. Clin. Nurs."},{"key":"441_CR40","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000008532","volume":"96","author":"F Sheng","year":"2017","unstructured":"Sheng, F., Fang, W., Zhang, B., Sha, Y. & Zeng, X. Adherence to gout management recommendations of Chinese patients. Medicine 96, e8532 (2017).","journal-title":"Medicine"},{"key":"441_CR41","doi-asserted-by":"publisher","first-page":"1490","DOI":"10.1136\/annrheumdis-2011-200801","volume":"71","author":"K Spencer","year":"2012","unstructured":"Spencer, K., Carr, A. & Doherty, M. Patient and provider barriers to effective management of gout in general practice: a qualitative study. Ann. Rheum. Dis. 71, 1490\u20131495 (2012).","journal-title":"Ann. Rheum. Dis."},{"key":"441_CR42","doi-asserted-by":"crossref","first-page":"15","DOI":"10.7812\/TPP\/15-234","volume":"20","author":"R Goldfien","year":"2016","unstructured":"Goldfien, R., Pressman, A., Jacobson, A., Ng, M. & Avins, A. A pharmacist-staffed, virtual gout management clinic for achieving target serum uric acid levels: a randomized clinical trial. Perm. J. 20, 15\u2013234 (2016).","journal-title":"Perm. J."},{"key":"441_CR43","doi-asserted-by":"publisher","first-page":"1403","DOI":"10.1016\/S0140-6736(18)32158-5","volume":"392","author":"M Doherty","year":"2018","unstructured":"Doherty, M. et al. Efficacy and cost-effectiveness of nurse-led care involving education and engagement of patients and a treat-to-target urate-lowering strategy versus usual care for gout: a randomised controlled trial. Lancet 392, 1403\u20131412 (2018).","journal-title":"Lancet"},{"key":"441_CR44","doi-asserted-by":"publisher","first-page":"1048","DOI":"10.1136\/annrheumdis-2017-212288","volume":"77","author":"N Dalbeth","year":"2018","unstructured":"Dalbeth, N. et al. Relationship between serum urate concentration and clinically evident incident gout: an individual participant data analysis. Ann. Rheum. Dis. 77, 1048\u20131052 (2018).","journal-title":"Ann. Rheum. Dis."},{"key":"441_CR45","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1186\/s13075-018-1612-1","volume":"20","author":"PL Evans","year":"2018","unstructured":"Evans, P. L. et al. Obesity, hypertension and diuretic use as risk factors for incident gout: a systematic review and meta-analysis of cohort studies. Arthritis Res. Ther. 20, 136 (2018).","journal-title":"Arthritis Res. Ther."},{"key":"441_CR46","doi-asserted-by":"publisher","first-page":"2145","DOI":"10.1093\/rheumatology\/key229","volume":"57","author":"SC Larsson","year":"2018","unstructured":"Larsson, S. C., Burgess, S. & Micha\u00eblsson, K. Genetic association between adiposity and gout: a Mendelian randomization study. Rheumatology 57, 2145\u20132148 (2018).","journal-title":"Rheumatology"},{"key":"441_CR47","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1136\/annrheumdis-2016-209958","volume":"76","author":"C Maglio","year":"2017","unstructured":"Maglio, C. et al. Effects of bariatric surgery on gout incidence in the Swedish Obese Subjects study: a non-randomised, prospective, controlled intervention trial. Ann. Rheum. Dis. 76, 688\u2013693 (2017).","journal-title":"Ann. Rheum. Dis."},{"key":"441_CR48","doi-asserted-by":"publisher","first-page":"1933","DOI":"10.1002\/art.39115","volume":"67","author":"GG Teng","year":"2015","unstructured":"Teng, G. G., Pan, A., Yuan, J.-M. & Koh, W.-P. Food sources of protein and risk of incident gout in the Singapore Chinese Health Study. Arthritis Rheumatol. 67, 1933\u20131942 (2015).","journal-title":"Arthritis Rheumatol."},{"key":"441_CR49","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2018-024171","volume":"9","author":"S Ayoub-Charette","year":"2019","unstructured":"Ayoub-Charette, S. et al. Important food sources of fructose-containing sugars and incident gout: a systematic review and meta-analysis of prospective cohort studies. BMJ Open 9, e024171 (2019).","journal-title":"BMJ Open"},{"key":"441_CR50","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2016-013191","volume":"6","author":"J Jamnik","year":"2016","unstructured":"Jamnik, J. et al. Fructose intake and risk of gout and hyperuricemia: a systematic review and meta-analysis of prospective cohort studies. BMJ Open 6, e013191 (2016).","journal-title":"BMJ Open"},{"key":"441_CR51","doi-asserted-by":"publisher","first-page":"j1794","DOI":"10.1136\/bmj.j1794","volume":"357","author":"SK Rai","year":"2017","unstructured":"Rai, S. K. et al. The Dietary Approaches to Stop Hypertension (DASH) diet, Western diet, and risk of gout in men: prospective cohort study. BMJ 357, j1794 (2017).","journal-title":"BMJ"},{"key":"441_CR52","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1016\/j.clnu.2019.03.016","volume":"39","author":"THT Chiu","year":"2020","unstructured":"Chiu, T. H. T., Liu, C.-H., Chang, C.-C., Lin, M.-N. & Lin, C.-L. Vegetarian diet and risk of gout in two separate prospective cohort studies. Clin. Nutr. 39, 837\u2013844 (2020).","journal-title":"Clin. Nutr."},{"key":"441_CR53","doi-asserted-by":"publisher","first-page":"k3951","DOI":"10.1136\/bmj.k3951","volume":"363","author":"TJ Major","year":"2018","unstructured":"Major, T. J., Topless, R. K., Dalbeth, N. & Merriman, T. R. Evaluation of the diet wide contribution to serum urate levels: meta-analysis of population based cohorts. BMJ 363, k3951 (2018).","journal-title":"BMJ"},{"key":"441_CR54","first-page":"k3951","volume":"363","author":"SK Rai","year":"2018","unstructured":"Rai, S. K., Zhang, Y., Hu, F. B., Pearce, N. & Choi, H. K. The paradox of ubiquitous risk factors for gout. BMJ 363, k3951 (2018).","journal-title":"BMJ"},{"key":"441_CR55","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1002\/art.41067","volume":"72","author":"HK Choi","year":"2020","unstructured":"Choi, H. K. et al. Population impact attributable to modifiable risk factors for hyperuricemia. Arthritis Rheumatol. 72, 157\u2013165 (2020).","journal-title":"Arthritis Rheumatol."},{"key":"441_CR56","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1136\/annrheumdis-2014-206410","volume":"75","author":"C-F Kuo","year":"2016","unstructured":"Kuo, C.-F., Grainge, M. J., Mallen, C., Zhang, W. & Doherty, M. Comorbidities in patients with gout prior to and following diagnosis: case-control study. Ann. Rheum. Dis. 75, 210\u2013217 (2016).","journal-title":"Ann. Rheum. Dis."},{"key":"441_CR57","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/s41927-019-0060-0","volume":"3","author":"DH Jaffe","year":"2019","unstructured":"Jaffe, D. H. et al. Incident gout and chronic kidney disease: healthcare utilization and survival. BMC Rheumatol. 3, 11 (2019).","journal-title":"BMC Rheumatol."},{"key":"441_CR58","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1186\/s13075-018-1746-1","volume":"20","author":"M Roughley","year":"2018","unstructured":"Roughley, M. et al. Risk of chronic kidney disease in patients with gout and the impact of urate lowering therapy: a population-based cohort study. Arthritis Res. Ther. 20, 243 (2018).","journal-title":"Arthritis Res. Ther."},{"key":"441_CR59","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1186\/s12882-019-1274-5","volume":"20","author":"JA Singh","year":"2019","unstructured":"Singh, J. A. & Cleveland, J. D. Gout is associated with a higher risk of chronic renal disease in older adults: a retrospective cohort study of U.S. Medicare population. BMC Nephrol. 20, 93 (2019).","journal-title":"BMC Nephrol."},{"key":"441_CR60","doi-asserted-by":"publisher","first-page":"577","DOI":"10.2215\/CJN.06790616","volume":"12","author":"VS Tan","year":"2017","unstructured":"Tan, V. S. et al. The 3-year incidence of gout in elderly patients with CKD. Clin. J. Am. Soc. Nephrol. 12, 577\u2013584 (2017).","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"441_CR61","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1186\/s13075-018-1596-x","volume":"20","author":"P Drivelegka","year":"2018","unstructured":"Drivelegka, P., Sigurdardottir, V., Sv\u00e4rd, A., Jacobsson, L. T. H. & Dehlin, M. Comorbidity in gout at the time of first diagnosis: sex differences that may have implications for dosing of urate lowering therapy. Arthritis Res. Ther. 20, 108 (2018).","journal-title":"Arthritis Res. Ther."},{"key":"441_CR62","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1136\/annrheumdis-2014-205252","volume":"74","author":"LE Clarson","year":"2015","unstructured":"Clarson, L. E. et al. Increased risk of vascular disease associated with gout: a retrospective, matched cohort study in the UK Clinical Practice Research Datalink. Ann. Rheum. Dis. 74, 642\u2013647 (2015).","journal-title":"Ann. Rheum. Dis."},{"key":"441_CR63","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1186\/s13075-017-1322-0","volume":"19","author":"A Abdul Sultan","year":"2017","unstructured":"Abdul Sultan, A. et al. Gout and subsequent erectile dysfunction: a population-based cohort study from England. Arthritis Res. Ther. 19, 123 (2017).","journal-title":"Arthritis Res. Ther."},{"key":"441_CR64","doi-asserted-by":"publisher","first-page":"1898","DOI":"10.3899\/jrheum.141105","volume":"42","author":"YF Chen","year":"2015","unstructured":"Chen, Y. F. et al. Gout and a subsequent increased risk of erectile dysfunction in men aged 64 and under: a nationwide cohort study in Taiwan. J. Rheumatol. 42, 1898\u20131905 (2015).","journal-title":"J. Rheumatol."},{"key":"441_CR65","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1016\/j.ejim.2015.06.001","volume":"26","author":"CY Hsu","year":"2015","unstructured":"Hsu, C. Y., Lin, C. L. & Kao, C. H. Gout is associated with organic and psychogenic erectile dysfunction. Eur. J. Intern. Med. 26, 691\u2013695 (2015).","journal-title":"Eur. J. Intern. Med."},{"key":"441_CR66","doi-asserted-by":"publisher","DOI":"10.1136\/rmdopen-2018-000712","volume":"4","author":"JA Singh","year":"2018","unstructured":"Singh, J. A. & Cleveland, J. D. Gout and the risk of incident atrial fibrillation in older adults: a study of US Medicare data. RMD Open 4, e000712 (2018).","journal-title":"RMD Open"},{"key":"441_CR67","doi-asserted-by":"publisher","DOI":"10.1038\/srep32220","volume":"6","author":"YJ Kuo","year":"2016","unstructured":"Kuo, Y. J. et al. The risk of atrial fibrillation in patients with gout: a nationwide population-based study. Sci. Rep. 6, 32220 (2016).","journal-title":"Sci. Rep."},{"key":"441_CR68","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1093\/rheumatology\/kev418","volume":"55","author":"CF Kuo","year":"2016","unstructured":"Kuo, C. F., Grainge, M. J., Mallen, C., Zhang, W. & Doherty, M. Impact of gout on the risk of atrial fibrillation. Rheumatology 55, 721\u2013728 (2016).","journal-title":"Rheumatology"},{"key":"441_CR69","doi-asserted-by":"publisher","first-page":"1473","DOI":"10.1136\/annrheumdis-2015-208161","volume":"75","author":"SC Kim","year":"2016","unstructured":"Kim, S. C., Liu, J. & Solomon, D. H. Risk of incident atrial fibrillation in gout: a cohort study. Ann. Rheum. Dis. 75, 1473\u20131478 (2016).","journal-title":"Ann. Rheum. Dis."},{"key":"441_CR70","first-page":"534","volume":"135","author":"JD Hasday","year":"1987","unstructured":"Hasday, J. D. & Grum, C. M. Nocturnal increase of urinary uric acid:creatinine ratio. A biochemical correlate of sleep-associated hypoxemia. Am. Rev. Respir. Dis. 135, 534\u2013538 (1987).","journal-title":"Am. Rev. Respir. Dis."},{"key":"441_CR71","doi-asserted-by":"publisher","first-page":"4145","DOI":"10.2174\/138161205774913255","volume":"11","author":"GK Glantzounis","year":"2005","unstructured":"Glantzounis, G. K., Tsimoyiannis, E. C., Kappas, A. M. & Galaris, D. A. Uric acid and oxidative stress. Curr. Pharm. Des. 11, 4145\u20134151 (2005).","journal-title":"Curr. Pharm. Des."},{"key":"441_CR72","doi-asserted-by":"publisher","first-page":"3298","DOI":"10.1002\/art.39330","volume":"67","author":"Y Zhang","year":"2015","unstructured":"Zhang, Y. et al. Sleep apnea and the risk of incident gout: a population-based, body mass index-matched cohort study. Arthritis Rheumatol. 67, 3298\u20133302 (2015).","journal-title":"Arthritis Rheumatol."},{"key":"441_CR73","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1002\/art.40662","volume":"71","author":"M Blagojevic-Bucknall","year":"2019","unstructured":"Blagojevic-Bucknall, M. et al. The risk of gout among patients with sleep apnea: a matched cohort study. Arthritis Rheumatol. 71, 154\u2013160 (2019).","journal-title":"Arthritis Rheumatol."},{"key":"441_CR74","doi-asserted-by":"publisher","first-page":"1521","DOI":"10.5664\/jcsm.7328","volume":"14","author":"JA Singh","year":"2018","unstructured":"Singh, J. A. & Cleveland, J. D. Gout and the risk of incident obstructive sleep apnea in adults 65 years or older: an observational study. J. Clin. Sleep. Med. 14, 1521\u20131527 (2018).","journal-title":"J. Clin. Sleep. Med."},{"key":"441_CR75","doi-asserted-by":"publisher","first-page":"2041","DOI":"10.1007\/s00264-018-4033-5","volume":"42","author":"Y Wang","year":"2018","unstructured":"Wang, Y. et al. Association of gout with osteoporotic fractures. Int. Orthop. 42, 2041\u20132047 (2018).","journal-title":"Int. Orthop."},{"key":"441_CR76","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000004669","volume":"95","author":"H-E Tzeng","year":"2016","unstructured":"Tzeng, H.-E., Lin, C.-C., Wang, I. K., Huang, P.-H. & Tsai, C.-H. Gout increases risk of fracture: a nationwide population-based cohort study. Medicine 95, e4669 (2016).","journal-title":"Medicine"},{"key":"441_CR77","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1002\/art.39852","volume":"69","author":"JM Paik","year":"2017","unstructured":"Paik, J. M. et al. Gout and risk of fracture in women: a prospective cohort study. Arthritis Rheumatol. 69, 422\u2013428 (2017).","journal-title":"Arthritis Rheumatol."},{"key":"441_CR78","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1007\/s00198-018-4375-2","volume":"29","author":"VC Kok","year":"2018","unstructured":"Kok, V. C. et al. Gout as a risk factor for osteoporosis: epidemiologic evidence from a population-based longitudinal study involving 108,060 individuals. Osteoporos. Int. 29, 973\u2013985 (2018).","journal-title":"Osteoporos. Int."},{"key":"441_CR79","doi-asserted-by":"publisher","first-page":"E581","DOI":"10.1503\/cmaj.170806","volume":"190","author":"AA Sultan","year":"2018","unstructured":"Sultan, A. A. et al. Risk of fragility fracture among patients with gout and the effect of urate-lowering therapy. CMAJ 190, E581\u2013E587 (2018).","journal-title":"CMAJ"},{"key":"441_CR80","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1002\/jbmr.2978","volume":"32","author":"SC Kim","year":"2017","unstructured":"Kim, S. C., Paik, J. M., Liu, J., Curhan, G. C. & Solomon, D. H. Gout and the risk of non-vertebral fracture. J. Bone Miner. Res. 32, 230\u2013236 (2017).","journal-title":"J. Bone Miner. Res."},{"key":"441_CR81","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000002140","volume":"94","author":"CC Huang","year":"2015","unstructured":"Huang, C. C. et al. An independent risk of gout on the development of deep vein thrombosis and pulmonary embolism: a nationwide, population-based cohort study. Medicine 94, e2140 (2015).","journal-title":"Medicine"},{"key":"441_CR82","doi-asserted-by":"publisher","DOI":"10.1038\/srep26541","volume":"6","author":"CC Chiu","year":"2016","unstructured":"Chiu, C. C. et al. Association between previous history of gout attack and risk of deep vein thrombosis \u2013 a nationwide population-based cohort study. Sci. Rep. 6, 26541 (2016).","journal-title":"Sci. Rep."},{"key":"441_CR83","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1093\/rheumatology\/kez398","volume":"59","author":"L Li","year":"2020","unstructured":"Li, L. et al. Trends of venous thromboembolism risk before and after diagnosis of gout: a general population-based study. Rheumatology 59, 1099\u20131107 (2020).","journal-title":"Rheumatology"},{"key":"441_CR84","doi-asserted-by":"publisher","first-page":"E597","DOI":"10.1503\/cmaj.180717","volume":"191","author":"AA Sultan","year":"2019","unstructured":"Sultan, A. A. et al. Venous thromboembolism in patients with gout and the impact of hospital admission, disease duration and urate-lowering therapy. CMAJ 191, E597\u2013E603 (2019).","journal-title":"CMAJ"},{"key":"441_CR85","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1016\/j.thromres.2016.06.020","volume":"144","author":"Y Kubota","year":"2016","unstructured":"Kubota, Y., McAdams-DeMarco, M. & Folsom, A. R. Serum uric acid, gout, and venous thromboembolism: the Atherosclerosis Risk In Communities Study. Thromb. Res. 144, 144\u2013148 (2016).","journal-title":"Thromb. Res."},{"key":"441_CR86","doi-asserted-by":"publisher","first-page":"815","DOI":"10.3904\/kjim.2016.062","volume":"33","author":"JH Jung","year":"2018","unstructured":"Jung, J. H. et al. Metabolic syndrome: prevalence and risk factors in Korean gout patients. Korean J. Intern. Med. 33, 815\u2013822 (2018).","journal-title":"Korean J. Intern. Med."},{"key":"441_CR87","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1002\/art.22466","volume":"57","author":"HK Choi","year":"2007","unstructured":"Choi, H. K., Ford, E. S., Li, C. & Curhan, G. Prevalence of the metabolic syndrome in patients with gout: the Third National Health and Nutrition Examination Survey. Arthritis Rheum. 57, 109\u2013115 (2007).","journal-title":"Arthritis Rheum."},{"key":"441_CR88","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.jbspin.2014.07.002","volume":"82","author":"F-Y Tu","year":"2015","unstructured":"Tu, F.-Y. et al. Prevalence of gout with comorbidity aggregations in southern Taiwan. Joint Bone Spine 82, 45\u201351 (2015).","journal-title":"Joint Bone Spine"},{"key":"441_CR89","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1136\/annrheumdis-2013-203779","volume":"74","author":"P Richette","year":"2015","unstructured":"Richette, P., Clerson, P., P\u00e9rissin, L., Flipo, R.-M. & Bardin, T. Revisiting comorbidities in gout: a cluster analysis. Ann. Rheum. Dis. 74, 142\u2013147 (2015).","journal-title":"Ann. Rheum. Dis."},{"key":"441_CR90","doi-asserted-by":"publisher","first-page":"1358","DOI":"10.1093\/rheumatology\/key096","volume":"57","author":"M Bevis","year":"2018","unstructured":"Bevis, M., Blagojevic-Bucknall, M., Mallen, C., Hider, S. & Roddy, E. Comorbidity clusters in people with gout: an observational cohort study with linked medical record review. Rheumatology 57, 1358\u20131363 (2018).","journal-title":"Rheumatology"},{"key":"441_CR91","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1007\/s00296-016-3634-9","volume":"37","author":"C-F Huang","year":"2017","unstructured":"Huang, C.-F. et al. Longitudinal transition trajectory of gouty arthritis and its comorbidities: a population-based study. Rheumatol. Int. 37, 313\u2013322 (2017).","journal-title":"Rheumatol. Int."},{"key":"441_CR92","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.1016\/S0140-6736(17)32154-2","volume":"390","author":"GBD 2016 Disease and Injury Incidence and Prevalence Collaborators","year":"2017","unstructured":"GBD 2016 Disease and Injury Incidence and Prevalence Collaborators. Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990\u20132016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet 390, 1211\u20131259 (2017).","journal-title":"Lancet"},{"key":"441_CR93","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1016\/S0140-6736(14)60460-8","volume":"384","author":"M Ng","year":"2014","unstructured":"Ng, M. et al. Global, regional, and national prevalence of overweight and obesity in children and adults during 1980\u20132013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet 384, 766\u2013781 (2014).","journal-title":"Lancet"},{"key":"441_CR94","doi-asserted-by":"publisher","first-page":"1417","DOI":"10.1002\/acr.22856","volume":"68","author":"G-M Han","year":"2016","unstructured":"Han, G.-M., Michaud, K., Yu, F., Watanabe-Galloway, S. & Mikuls, T. R. Increasing public health burden of arthritis and other rheumatic conditions and comorbidity: results from a Statewide Health Surveillance System, 2007\u20132012. Arthritis Care Res. 68, 1417\u20131427 (2016).","journal-title":"Arthritis Care Res."},{"key":"441_CR95","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1007\/s10067-018-3983-8","volume":"37","author":"AA Kiadaliri","year":"2018","unstructured":"Kiadaliri, A. A. & Englund, M. Temporal trends and regional disparity in rheumatoid arthritis and gout hospitalizations in Sweden, 1998\u20132015. Clin. Rheumatol. 37, 825\u2013830 (2018).","journal-title":"Clin. Rheumatol."},{"key":"441_CR96","doi-asserted-by":"publisher","first-page":"2345","DOI":"10.1001\/jama.2016.3517","volume":"315","author":"SY Lim","year":"2016","unstructured":"Lim, S. Y. et al. Trends in gout and rheumatoid arthritis hospitalizations in the United States, 1993\u20132011. JAMA 315, 2345\u20132347 (2016).","journal-title":"JAMA"},{"key":"441_CR97","doi-asserted-by":"publisher","first-page":"619","DOI":"10.3899\/jrheum.190257","volume":"47","author":"M Russell","year":"2020","unstructured":"Russell, M. et al. Rising incidence of acute hospital admissions due to gout. J. Rheumatol. 47, 619\u2013623 (2020).","journal-title":"J. Rheumatol."},{"key":"441_CR98","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1111\/1756-185X.12941","volume":"20","author":"PC Robinson","year":"2017","unstructured":"Robinson, P. C., Kempe, S., Tebbutt, I. & Roberts, L. Epidemiology of inpatient gout in Australia and New Zealand: temporal trends, comorbidities and gout flare site. Int. J. Rheum. Dis. 20, 779\u2013784 (2017).","journal-title":"Int. J. Rheum. Dis."}],"container-title":["Nature Reviews Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/s41584-020-0441-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41584-020-0441-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41584-020-0441-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T18:22:11Z","timestamp":1684606931000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41584-020-0441-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6,15]]},"references-count":98,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2020,7]]}},"alternative-id":["441"],"URL":"https:\/\/doi.org\/10.1038\/s41584-020-0441-1","relation":{},"ISSN":["1759-4790","1759-4804"],"issn-type":[{"value":"1759-4790","type":"print"},{"value":"1759-4804","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,6,15]]},"assertion":[{"value":"11 May 2020","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 June 2020","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}